| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 17 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 17 |
| 2 | TACROLIMUS OINTMENT 0.1% | 17 |
| 3 | PREDNISONE | 15 |
| 4 | DARATUMUMAB | 13 |
| 5 | MYCOPHENOLATE MOFETIL | 11 |
| 6 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 11 |
| 7 | ACYCLOVIR | 10 |
| 8 | ALBUTEROL SULFATE | 9 |
| 9 | DEXAMETHASONE | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CIDOFOVIR ANHYDROUS | 2 | 0.0014 |
| 1 | DEXTROMETHORPHAN POLISTIREX | 1 | 0.0013 |
| 2 | MARAVIROC | 3 | 0.0013 |
| 3 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 8 | 0.0010 |
| 4 | CLEAR MINT, GEL TOOTHPASTE | 1 | 0.0009 |
| 5 | STIRIPENTOL | 2 | 0.0009 |
| 6 | CLOFARABINE | 2 | 0.0009 |
| 7 | CALCIFEDIOL | 2 | 0.0008 |
| 8 | CILTACABTAGENE AUTOLEUCEL | 5 | 0.0008 |
| 9 | ANIFROLUMAB-FNIA | 1 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD38-directed Cytolytic Antibody [EPC] | 15 | 0.0026 |
| 1 | CCR5 Co-receptor Antagonist [EPC] | 3 | 0.0013 |
| 2 | Type I Interferon Receptor Antagonist [EPC] | 1 | 0.0005 |
| 3 | Isocitrate Dehydrogenase 1 Inhibitor [EPC] | 1 | 0.0005 |
| 4 | Sulfone [EPC] | 4 | 0.0004 |
| 5 | Carnitine Analog [EPC] | 1 | 0.0003 |
| 6 | Provitamin D2 Compound [EPC] | 8 | 0.0003 |
| 7 | Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] | 2 | 0.0003 |
| 8 | Human Immunoglobulin G [EPC] | 4 | 0.0002 |
| 9 | Cardiac Myosin Inhibitor [EPC] | 1 | 0.0002 |